Developer, Prime plc, University Hospital Southampton NHS Foundation Trust (UHS), Willmott Dixon, Macquarie Group, and IHSS, say the ‘milestone’ emphasises the growing impact of public-private collaboration in the healthcare sector.
Located within the campus’s Plot 2, the new facility houses ‘a highly specialised’ aseptic pharmacy and Sterile Services Department. It will also produce sterile medicines for University Hospital Southampton and other NHS providers across the region. One of the pharmacy’s capabilities will be the upcoming production of TBN, ‘a vital drug’ for premature babies, which will be produced exclusively there for the entire southern UK.
To ensure the highest cleanliness and safety standards, the facility’s construction involved both the main contractor, Willmott Dixon, and Enblock – a specialist in delivering design and build cleanrooms. The development has achieved BREEAM ‘Excellent’ certification, and features numerous photovoltaic panels to generate ‘clean energy’.
Prime said: “Working in partnership with service delivery partner, IHSS, the project highlights the success and value of public-private partnerships in addressing the growing demands of healthcare infrastructure. The facility will support UHS, one of the UK’s largest and busiest teaching hospitals, by alleviating space constraints and bolstering the hospital’s ability to provide cutting-edge care to patients.”
Phil Holland, Chief Investment Officer at Prime, said: “These new facilities are a critical step in enhancing Southampton’s medical capabilities and preserving vital clinical space for UHS. They represent a strong collaboration between the public and private sectors, with the shared goal of ensuring that the region remains at the forefront of healthcare excellence and sustainability.”
Sam Morton, MD at IHSS, said: “We are incredibly proud of the collaboration between IHSS, our partners, and the dedicated teams working on this state-of-the-art supercentre. We look forward to the positive impact this facility will have on providing world-class decontamination services in the region.
Richard Poulter, managing director at Willmott Dixon Construction South, added: “We are proud to have played a key role in delivering these state-of-the-art healthcare facilities at Adanac Health and Innovation Campus. This project showcases the power of collaboration in addressing the evolving needs of the NHS and the wider healthcare sector. By combining innovative design, specialist expertise, and a strong sustainability focus, we have created a facility that will make a lasting impact on patient care and medical services across the region.”